54-97-7 | 2-Phenylcyclopropan-1-amine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$171.00	$120.00
5g	98%	in stock	$527.00	$369.00
10g	98%	in stock	$869.00	$608.00
25g	98%	in stock	$2,004.00	$1,403.00

Description

• Catalog Number: AG52845
• Chemical Name: 2-Phenylcyclopropan-1-amine
• CAS Number: 54-97-7
• Molecular Formula: C9H11N
• Molecular Weight: 133.1903
• MDL Number: MFCD04114536
• SMILES: NC1CC1c1ccccc1
• NSC Number: 80664

Computed Properties

• Complexity: 116
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• Undefined Atom Stereocenter Count: 2
• XLogP3: 1.5

Literature

• In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding.

  Toxicology in vitro : an international journal published in association with BIBRA 20170401

• Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

  Toxicology letters 20160122

• Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.

  Journal of medicinal chemistry 20140612

• Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.

  Chemico-biological interactions 20131125

• Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system.

  Toxicology in vitro : an international journal published in association with BIBRA 20130901

• Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

  Journal of applied toxicology : JAT 20130201

• A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

  mBio 20130101

• In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine.

  Molecular pharmacology 20121101

• Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.

  Neuroscience letters 20121018

• Oncoepigenomics: making histone lysine methylation count.

  European journal of medicinal chemistry 20121001

• Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.

  Drug metabolism and disposition: the biological fate of chemicals 20120901

• Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.

  Human pathology 20120801

• Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases.

  Journal of clinical psychopharmacology 20120801

• Novel colorimetric assay of LSD1 activity using gold nanoparticles.

  The Analyst 20120607

• [Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell].

  Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20120601

• Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations.

  Behavioural brain research 20120421

• Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120401

• FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure.

  Nature communications 20120327

• Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.

  Nature medicine 20120311

• The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat.

  Pharmacology, biochemistry, and behavior 20120101

• Knockdown of menin affects pre-mRNA processing and promoter fidelity at the interferon-gamma inducible IRF1 gene.

  Epigenetics & chromatin 20120101

• Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

  Molecular carcinogenesis 20111201

• The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.

  Genes, chromosomes & cancer 20111201

• Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors.

  Human pathology 20111101

• Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells.

  Cell research 20111001

• Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.

  Chemico-biological interactions 20110905

• Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.

  Neuro-oncology 20110801

• The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats.

  Neurochemistry international 20110801

• Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1).

  PLoS pathogens 20110801

• Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

  British journal of pharmacology 20110701

• Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.

  Bioorganic & medicinal chemistry 20110615

• Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events.

  Molecular and cellular endocrinology 20110606

• Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration.

  Synapse (New York, N.Y.) 20110601

• Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics.

  Drug metabolism and disposition: the biological fate of chemicals 20110301

• Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.

  European journal of drug metabolism and pharmacokinetics 20110301

• Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors.

  Journal of clinical psychopharmacology 20110201

• Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist.

  Drug metabolism and disposition: the biological fate of chemicals 20110101

• The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

  Neuropharmacology 20110101

• Chemical biology of lysine demethylases.

  Current chemical genomics 20110101

• Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming.

  Stem cells international 20110101

• On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.

  Pharmacological research 20101201

• Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

  The Journal of biological chemistry 20101119

• Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide.

  Pharmacopsychiatry 20101101

• Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.

  The Journal of biological chemistry 20101008

• [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].

  Psychiatrische Praxis 20101001

• Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .

  Biochemistry 20100803

• limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.

  Neurotoxicity research 20100801

• Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.

  Journal of clinical psychopharmacology 20100801

• Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.

  Journal of the American Chemical Society 20100519

• Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.

  Journal of the American Chemical Society 20100310

• Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats.

  Psychopharmacology 20100301

• Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.

  Psychiatry research 20100227

• Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy.

  Chemical research in toxicology 20100101

• Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme.

  Neurotoxicology 20100101

• Gas chromatography-mass spectrometry detection of a norfluoxetine artifact in hydrolyzed urine samples may falsely indicate tranylcypromine ingestion.

  Journal of analytical toxicology 20100101

• Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.

  European journal of clinical pharmacology 20091201

• TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability.

  Biochemical pharmacology 20091201

• Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.

  Stem cells (Dayton, Ohio) 20091201

• Ovariectomy increases the formation of prostanoids and modulates their role in acetylcholine-induced relaxation and nitric oxide release in the rat aorta.

  Cardiovascular research 20091101

• Ti: myths about monoamine oxidase inhibitors perpetuated.

  The Australian and New Zealand journal of psychiatry 20091101

• Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.

  The Biochemical journal 20091023

• Trans-2-phenylcyclopropylamine induces nerve cells apoptosis in zebrafish mediated by depression of LSD1 activity.

  Brain research bulletin 20090828

• Commentary on STAR*D: a summary and UK perspective.

  Journal of psychopharmacology (Oxford, England) 20090801

• Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.

  Toxicology in vitro : an international journal published in association with BIBRA 20090601

• Tranylcypromine dependence and withdrawal.

  The Australian and New Zealand journal of psychiatry 20090601

• [Irreversible, non-selective monoamine oxidase inhibitors].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090416

• Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.

  Journal of medicinal chemistry 20090409

• Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells.

  European journal of pharmacology 20090214

• Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128

• Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

  Retrovirology 20090101

• Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice.

  Psychopharmacology 20081201

• Antidepressant activity of curcumin: involvement of serotonin and dopamine system.

  Psychopharmacology 20081201

• Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

  Journal of neural transmission (Vienna, Austria : 1996) 20081201

• Electroconvulsive therapy and monoamine oxidase inhibitors.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201

• Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.

  Drug metabolism and disposition: the biological fate of chemicals 20081101

• Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.

  Pharmacopsychiatry 20081101

• Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.

  Synapse (New York, N.Y.) 20080801

• Complexes of the copper-containing amine oxidase from Arthrobacter globiformis with the inhibitors benzylhydrazine and tranylcypromine.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20080701

• Chronic ouabain treatment increases the contribution of nitric oxide to endothelium-dependent relaxation.

  Journal of physiology and biochemistry 20080601

• Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.

  Bioorganic & medicinal chemistry letters 20080515

• Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.

  Psychopharmacology 20080401

• Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

  Neurochemical research 20080301

• Withdrawal from high-dose tranylcypromine.

  Clinical toxicology (Philadelphia, Pa.) 20080301

• Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.

  Biochemical and biophysical research communications 20080201

• Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.

  PloS one 20080101

• [The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?].

  Tijdschrift voor psychiatrie 20080101

• The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.

  Psychopharmacology 20071101

• Not all monoamine oxidase inhibitors are created equal.

  Journal of the American Geriatrics Society 20071101

• Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice.

  Neuropharmacology 20071001

• Transdermal selegiline for the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20071001

• Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat.

  Psychopharmacology 20070901

• Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

  Journal of psychiatry & neuroscience : JPN 20070901

• Reduced evoked fos expression in activity-related brain regions in animal models of behavioral depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20070815

• Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.

  Biochemistry 20070710

• Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.

  Synapse (New York, N.Y.) 20070601

• Tranylcypromine enhancement of nicotine self-administration.

  Neuropharmacology 20070501

• Under-recruitment of patients for clinical trials: an illustrative example of a failed study.

  Acta psychiatrica Scandinavica 20070501

• Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.

  Acta psychiatrica Scandinavica 20070501

• trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.

  Biochemistry 20070410

• STAR*D level IV methodology.

  The American journal of psychiatry 20070401

• Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine.

  The American journal of psychiatry 20070401

• Motor cortex excitability after vagus nerve stimulation in major depression.

  Journal of clinical psychopharmacology 20070401

• Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.

  Journal of clinical psychopharmacology 20070401

• Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent.

  Growth factors (Chur, Switzerland) 20070401

• Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.

  The American journal of psychiatry 20070301

• STAR*D: what have we learned?

  The American journal of psychiatry 20070201

• Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.

  European journal of pharmacology 20070105

• CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.

  Acta pharmacologica Sinica 20070101

• Hydrazine and amphetamine binding to amine oxidases: old drugs with new prospects.

  Journal of neural transmission (Vienna, Austria : 1996) 20070101

• Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

  Journal of clinical psychopharmacology 20061001

• Keeping our eyes on STAR*D.

  The American journal of psychiatry 20060901

• Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

  The American journal of psychiatry 20060901

• Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.

  The European journal of neuroscience 20060901

• Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.

  Brain research 20060823

• Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.

  Journal of clinical pharmacology 20060801

• Tranylcypromine: new perspectives on an 'old' drug.

  European archives of psychiatry and clinical neuroscience 20060801

• Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.

  Life sciences 20060620

• Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.

  Chemistry & biology 20060601

• Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.

  CNS spectrums 20060501

• Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

  CNS spectrums 20060501

• Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models.

  International journal of pharmaceutics 20060309

• Nitric oxide synthesis is required for exercise-induced increases in hippocampal BDNF and phosphatidylinositol 3' kinase expression.

  Brain research bulletin 20060115

• Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine.

  European journal of medicinal chemistry 20051101

• [Metabolic kinetics of MN9202 in Beagle dog liver microsomes].

  Yao xue xue bao = Acta pharmaceutica Sinica 20051101

• The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.

  British journal of pharmacology 20051001

• Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans.

  Drug metabolism and disposition: the biological fate of chemicals 20050901

• Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus.

  Psychopharmacology 20050901

• The serotonin syndrome.

  The New England journal of medicine 20050609

• Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

  Journal of medicinal chemistry 20050602

• Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.

  Bioorganic & medicinal chemistry 20050516

• Do antihypertensives make tranylcypromine safer? Three case reports.

  The Journal of clinical psychiatry 20050501

• Exercise activates the phosphatidylinositol 3-kinase pathway.

  Brain research. Molecular brain research 20050427

• Receptor rigidity and ligand mobility in trypsin-ligand complexes.

  Proteins 20050201

• Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines.

  Arzneimittel-Forschung 20050101

• Antidepressant apathy syndrome.

  Perspectives in psychiatric care 20050101

• Endogenous prostacyclin increases neuronal nitric oxide release in mesenteric artery from spontaneously hypertensive rats.

  European journal of pharmacology 20041215

• Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidase.

  Journal of medicinal chemistry 20041118

• Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.

  The Journal of clinical psychiatry 20041101

• Medical implications from the crystal structure of a copper-containing amine oxidase complexed with the antidepressant drug tranylcypromine.

  FEBS letters 20041022

• Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus.

  Biochemical pharmacology 20041015

• Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.

  European journal of pharmacology 20040919

• Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report.

  Sleep medicine 20040901

• Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338.

  European journal of pharmacology 20040823

• Structure and mechanism of monoamine oxidase.

  Current medicinal chemistry 20040801

• Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats.

  Environmental health perspectives 20040801

• Monoamine oxidase inhibitors and subarachnoid hemorrhage.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801

• Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.

  Progress in neuro-psychopharmacology & biological psychiatry 20040701

• The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum.

  Brain research 20040625

• Validated assays for human cytochrome P450 activities.

  Drug metabolism and disposition: the biological fate of chemicals 20040601

• Involvement of ceramide in the mechanism of Cr(VI)-induced apoptosis of CHO cells.

  Free radical research 20040601

• Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.

  Bioorganic & medicinal chemistry 20040515

• Zinc treatment induces cortical brain-derived neurotrophic factor gene expression.

  European journal of pharmacology 20040510

• Purification and characterization of recombinant human prostacyclin synthase.

  Journal of biochemistry 20040401

• Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.

  Journal of medicinal chemistry 20040325

• Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain.

  Pharmacology, biochemistry, and behavior 20040201

• Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.

  Cellular and molecular neurobiology 20040201

• [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].

  Nederlands tijdschrift voor geneeskunde 20031004

• [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].

  Nederlands tijdschrift voor geneeskunde 20031004

• Successful suppression of cataplectic attacks with tramadol.

  Neurology 20030923

• Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors.

  Pharmacology, biochemistry, and behavior 20030901

• Fatal interaction between tranylcypromine and imipramine.

  European psychiatry : the journal of the Association of European Psychiatrists 20030801

• Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity.

  Journal of hepatology 20030601

• In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver.

  Xenobiotica; the fate of foreign compounds in biological systems 20030601

• Scaling down.

  The American journal of psychiatry 20030501

• Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine.

  Biochimica et biophysica acta 20030411

• Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant.

  Pharmacology, biochemistry, and behavior 20030401

• [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.

  Synapse (New York, N.Y.) 20030201

• Effects of stress and tranylcypromine on amphetamine-induced locomotor activity and GABA(B) receptor function in rat brain.

  Life sciences 20030117

• Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.

  Rapid communications in mass spectrometry : RCM 20030101

• Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder.

  Psychosomatic medicine 20030101

• Antidepressant drug treatment induces Arc gene expression in the rat brain.

  Neuroscience 20030101

• Effects of tranylcypromine on the sleep of patients with anergic bipolar depression.

  Psychopharmacology bulletin 20030101

• Endogenous nitric oxide reduces microvascular permeability and tissue oedema during exercise in cat skeletal muscle.

  Journal of vascular research 20030101

• Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.

  Neuropharmacology 20021101

• Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue.

  The Biochemical journal 20020801

• Successful treatment of a complicated case of neuroleptic malignant syndrome.

  Intensive care medicine 20020701

• The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19.

  Pharmaceutical research 20020701

• Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.

  Journal of medicinal chemistry 20020606

• Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.

  Journal of psychiatry & neuroscience : JPN 20020501

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).

  Journal of neural transmission (Vienna, Austria : 1996) 20020301

• Endothelin-1 reduces microvascular fluid permeability through secondary release of prostacyclin in cat Skeletal muscle.

  Microvascular research 20020101

• Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies.

  Placenta 20020101

• [Protease inhibitors as an anesthetic component in ENT surgery].

  Anesteziologiia i reanimatologiia 20020101

• [Use of transamine during general anesthesia in facial dermabrasion].

  Anesteziologiia i reanimatologiia 20020101

• Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.

  European journal of pharmacology 20011005

• Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.

  Life sciences 20010907

• Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

  Drug metabolism and disposition: the biological fate of chemicals 20010601

• Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines.

  European journal of medicinal chemistry 20010601

• Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries.

  Journal of cardiovascular pharmacology 20010501

• Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model.

  Behavioural brain research 20010408

• In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

  Drug metabolism and disposition: the biological fate of chemicals 20010301

• Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine.

  Neuropsychiatry, neuropsychology, and behavioral neurology 20010101

• Mimicking gene defects to treat drug dependence.

  Annals of the New York Academy of Sciences 20000101

• Stroke resulting from a rapid switch from phenelzine to tranylcypromine.

  The Journal of clinical psychiatry 19980701

• Experience with tranylcypromine in early Parkinson's disease.

  Journal of neural transmission. Supplementum 19980101

• [Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].

  Der Nervenarzt 19970701

• Serotonin syndrome from venlafaxine-tranylcypromine interaction.

  Veterinary and human toxicology 19961001

• Successful treatment of serotonin syndrome with chlorpromazine.

  The Medical journal of Australia 19960916

• Site-directed mutagenesis of human prostacyclin synthase: Alteration of Cys441 of the Cys-pocket, and Glu347 and Arg350 of the EXXR motif.

  FEBS letters 19960708

• Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 19960401

• Venlafaxine.

  Nursing 19960301

• Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19950501

• Fluoxetine and the serotonin syndrome.

  Annals of emergency medicine 19941101

• [A case of tranylcypromine-induced hallucination].

  Psychiatrische Praxis 19930501

• [Intracranial hemorrhage following use of MAO inhibitor tranylcypromine and beer].

  Nederlands tijdschrift voor geneeskunde 19930501

• Tranylcypromine withdrawal phenomena.

  Journal of psychiatry & neuroscience : JPN 19930101

• Abuse of monoamine oxidase inhibitors.

  The American journal of drug and alcohol abuse 19920101

• Capgras syndrome in association with lithium toxicity.

  The British journal of psychiatry : the journal of mental science 19911201

• Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome.

  Journal of clinical psychopharmacology 19910801

• Interaction of butorphanol, with monoamine oxidase inhibitor, tranylcypromine.

  Forensic science international 19910301

• Symptoms of major depression: acute effect of withdrawing antidepressants.

  Acta psychiatrica Scandinavica 19910301

• Treatment of panic disorder and benzodiazepine withdrawal with valproate.

  The Journal of neuropsychiatry and clinical neurosciences 19910101

• [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].

  Farmakologiia i toksikologiia 19910101

• Monosodium glutamate and tranylcypromine administration in healthy subjects.

  The Journal of clinical psychiatry 19900701

• Adverse consequences of fluoxetine-MAOI combination therapy.

  The Journal of clinical psychiatry 19900601

• Afternoon fatigue and somnolence associated with tranylcypromine treatment.

  The Journal of clinical psychiatry 19900501

• Hypertensive crisis precipitated by a monoamine oxidase inhibitor in a patient with phaeochromocytoma.

  BMJ (Clinical research ed.) 19900303

• Hypertensive episodes with tranylcypromine treatment.

  Journal of clinical psychopharmacology 19890601

• Hypertensive crisis and broad complex bradycardia after a single dose of monoamine oxidase inhibitor.

  BMJ (Clinical research ed.) 19890408

• Autoinduction of hypertensive reactions by tranylcypromine?

  Journal of clinical psychopharmacology 19890201

• Common side effects associated with monoamine oxidase inhibitors.

  Progress in neuro-psychopharmacology & biological psychiatry 19890101

• Severe daytime somnolence in patients treated with an MAOI.

  The American journal of psychiatry 19881201

• Buspirone-induced hypomania: a case report.

  Journal of clinical psychopharmacology 19880601

• Cardiac myonecrosis and monoamine oxidase inhibitor therapy.

  The American journal of medicine 19871001

• Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.

  Neuropharmacology 19870901

• Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction.

  Anaesthesia 19870701

• Treatment of MAOI hypertensive crisis with sublingual nifedipine.

  The Journal of clinical psychiatry 19870601

• Hypertension during anaesthesia with monoamine oxidase inhibitors.

  Anaesthesia 19870601

• Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy.

  The American journal of medicine 19870501

• Yohimbine- and tranylcypromine-induced postural hypotension.

  The American journal of psychiatry 19870101

• Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.

  The American journal of psychiatry 19851201

• Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.

  The New England journal of medicine 19850704

• Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.

  The American journal of psychiatry 19850401

• Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.

  Journal of clinical psychopharmacology 19850201

• Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.

  Acta physiologica Polonica 19840101

• The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.

  Archives of general psychiatry 19830601

• Does prostacyclin mediate alpha-adrenergic induced hypotension?

  Documenta ophthalmologica. Advances in ophthalmology 19820930

• Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants.

  The American journal of psychiatry 19820901

• Hypertensive crisis resulting from avocados and a MAO inhibitor.

  Drug intelligence & clinical pharmacy 19811101

• Atrial flutter/fibrillation associated with tranylcypromine treatment.

  Journal of clinical psychopharmacology 19811101

• Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.

  British journal of clinical pharmacology 19810501

• Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines.

  Journal of dental research 19810201

• Reduction of ECS-induced retrograde amnesia of passive avoidance conditioning after 5,7-dihydroxytryptamine median raphe nucleus lesion in the rat.

  Neuropsychobiology 19810101

• Linoleic acid in the treatment of lithium toxicity and familial tremor.

  Prostaglandins and medicine 19800401

• Hoarseness and aphonia as a side effect of tricyclic antidepressants.

  The American journal of psychiatry 19791201

• Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis.

  Prostaglandins and medicine 19791001

• Degraded protein-containing food and monoamine oxidase inhibitors.

  The American journal of psychiatry 19771201

• Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.

  British journal of pharmacology 19770201

• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

  Prostaglandins 19761101

• The tranylcypromine isomers: a controlled clinical trial.

  The American journal of psychiatry 19740901

• Letter: Side effect of tranylcypromine.

  British medical journal 19740831

• Tricyclic antidepressants and monoamine oxidase inhibitors.

  Archives of general psychiatry 19710601

• Severe hyperpyrexia due to tranylcypromine-amphetamine toxicity.

  Annals of internal medicine 19690301

• Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.

  Proceedings of the Western Pharmacology Society 19660101